Results 41 to 50 of about 6,625,307 (165)

Transanal Total Mesorectal Excision vs Laparoscopic Total Mesolectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis.

open access: yes, 2018
BACKGROUND: Transanal total mesorectal excision is a novel and promising technique in the treatment of low and middle rectal cancer. OBJECTIVE: This study aimed to compare the safety and feasibility of transanal total mesorectal excision versus ...
Alberto Biondi   +15 more
core   +1 more source

A Way to Start Transanal Total Mesorectal Excision for Rectal Cancer

open access: yesJournal of Coloproctology, 2022
Introduction The optimal rectal cancer care is achieved by a multidisciplinary approach, with a high-quality surgical resection, with complete mesorectal excision and adequate margins.
Ruben Martins   +7 more
doaj   +1 more source

Essential Updates in the Surgical Management of Inflammatory Bowel Disease: Current Topics From 2024 to Mid‐2026

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Inflammatory bowel disease management has undergone a major transformation with the introduction of treat‐to‐target strategies and highly effective biologic and small‐molecule therapies. Although these advances have reduced the overall requirement for surgery, operative intervention remains essential for selected patients with ulcerative ...
Yoshiki Okita   +4 more
wiley   +1 more source

Postoperative urinary retention following transanal versus laparoscopic total mesorectal excision for rectal cancer: A randomized trial report from an experienced center

open access: yesHeliyon
Background: Transanal total mesorectal excision has emerged as a potential solution to certain limitations associated with laparoscopic total mesorectal excision in rectal cancer patients.
Fujin Ye   +16 more
doaj   +1 more source

Statistical, Clinical, Methodological Evaluation of Local Recurrence Following Transanal Total Mesorectal Excision for Rectal Cancer: A Systematic Review

open access: yes, 2021
BACKGROUND: A recent Norwegian moratorium challenged the status quo of transanal total mesorectal excision for rectal cancer by reporting increased early multifocal local recurrences.
Feza H. Remzi   +13 more
core   +1 more source

Mid-term oncological outcomes of transanal total mesorectal excision for rectal cancer: a prospective, single center, randomized controlled trial

open access: yes结直肠肛门外科, 2022
[Objectives] To compare mid-term oncological outcomes between transanal total mesorectal excision (taTME) and laparoscopic total mesorectal excision (lapTME) for rectal cancer.
Zhu Yongfei   +13 more
doaj   +1 more source

A Rare Finding of Retroperitoneal Sepsis Following Robot‐Assisted Transanal Minimally Invasive Surgery (TAMIS): A Case Report and Review of the Literature

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Robot‐assisted transanal minimally invasive surgery (TAMIS) is a safe and effective platform for the local excision of early rectal lesions. While postoperative complications such as bleeding or contained perforation are recognized, rapidly progressive retroperitoneal sepsis remains an exceedingly rare occurrence.
Jonathan Tiong   +4 more
wiley   +1 more source

Evolution of surgery for rectal cancer: Transanal total mesorectal excision~new standard or fad?~

open access: yesJournal of the Anus, Rectum and Colon, 2018
Transanal Total Mesorectal Excision (TaTME) has recently been developed to overcome the difficulties associated with conventional laparoscopic or robotic TME.
Hirotoshi Hasegawa   +5 more
doaj   +1 more source

Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer

open access: yesJournal of Coloproctology, 2021
Introduction Transanal total mesorectal excision (TaTME) has revolutionized the surgical techniques for lower-third rectal cancer. The aim of the present study was to analyze the outcomes of quality indicators of TaTME for rectal cancer compared with ...
María Labalde Martínez   +8 more
doaj   +1 more source

Sexual dysfunction outcomes and reporting disparities after multimodal treatment for rectal cancer: A systematic review and narrative synthesis

open access: yesColorectal Disease, Volume 28, Issue 9, September 2026.
Abstract Background Sexual dysfunction is a recognised adverse outcome after rectal cancer treatments, yet reporting is predominantly male‐focused, with female sexual dysfunction less consistently assessed or reported. This systematic review aimed to assess sexual health domains studied, examine sex‐based reporting disparities, and identify limitations
Vignesh Lakshmanan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy